Table 1. Baseline characteristics of PLWHH with NADMs.
| Baseline characteristics | All patients n = 35 |
|---|---|
| Age (years), median (IQR) | 51 (47–62) |
| Haemophilia type | |
| A | 26 (74%) |
| B | 7 (20%) |
| History of AIDS | 5/34 (15%) |
| Treatment with ART | 33 (94%) |
| Duration of ART (years), median (IQR) | 22 (17–25) |
| HIV viral load < 50 copies/mL | 32 (94%) |
| CD4 cell count (/μL), median (IQR) | 405 (281–558) |
| CD8 cell count (/μL), median (IQR) | 470 (304–665) |
| CD4/CD8 ratio, median (IQR) | 0.87 (0.58–1.11) |
| HBsAg positivity | 2/34 (6%) |
| HCV-Ab positivity | 33/34 (97%) |
| HCV-RNA positivity | 4/32 (13%) |
| Current smoking | 6/34 (18%) |
| Heavy alcohol consumption | 2/34 (6%) |
| Solitary living | 10/34 (29%) |
Abbreviations: AIDS, acquired immunodeficiency syndrome; HIV, human immunodeficiency virus; IQR, interquartile range; ART, antiretroviral therapy; HBsAg, hepatitis B surface antigen; HCV-Ab, hepatitis C virus antibody; HCV-RNA, hepatitis C virus RNA; NADM, non-acquired immunodeficiency syndrome-defining malignancy; PLWHH, people living with haemophilia and the human immunodeficiency virus.